nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—KCNH2—Sunitinib—kidney cancer	0.141	0.246	CbGbCtD
Alfuzosin—CYP3A4—Everolimus—kidney cancer	0.127	0.221	CbGbCtD
Alfuzosin—CYP3A4—Temsirolimus—kidney cancer	0.0856	0.149	CbGbCtD
Alfuzosin—CYP3A4—Pazopanib—kidney cancer	0.045	0.0783	CbGbCtD
Alfuzosin—CYP3A4—Erlotinib—kidney cancer	0.0321	0.0559	CbGbCtD
Alfuzosin—CYP3A4—Paclitaxel—kidney cancer	0.0294	0.0512	CbGbCtD
Alfuzosin—CYP3A4—Sorafenib—kidney cancer	0.0261	0.0454	CbGbCtD
Alfuzosin—CYP3A4—Vinblastine—kidney cancer	0.0258	0.0449	CbGbCtD
Alfuzosin—CYP3A4—Vincristine—kidney cancer	0.0253	0.0441	CbGbCtD
Alfuzosin—CYP3A4—Sunitinib—kidney cancer	0.0211	0.0368	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—kidney cancer	0.0158	0.0276	CbGbCtD
Alfuzosin—Prazosin—CYP1A1—kidney cancer	0.00214	0.347	CrCbGaD
Alfuzosin—Terazosin—ABCB1—kidney cancer	0.00166	0.269	CrCbGaD
Alfuzosin—Doxazosin—ABCB1—kidney cancer	0.00123	0.2	CrCbGaD
Alfuzosin—Prazosin—ABCB1—kidney cancer	0.00114	0.184	CrCbGaD
Alfuzosin—Diarrhoea—Everolimus—kidney cancer	0.000454	0.00108	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000454	0.00108	CcSEcCtD
Alfuzosin—Hyperhidrosis—Vincristine—kidney cancer	0.000454	0.00108	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Capecitabine—kidney cancer	0.000454	0.00108	CcSEcCtD
Alfuzosin—Pruritus—Erlotinib—kidney cancer	0.000453	0.00108	CcSEcCtD
Alfuzosin—Fatigue—Dactinomycin—kidney cancer	0.000453	0.00108	CcSEcCtD
Alfuzosin—Pain—Dactinomycin—kidney cancer	0.000449	0.00107	CcSEcCtD
Alfuzosin—Oedema—Gemcitabine—kidney cancer	0.000445	0.00106	CcSEcCtD
Alfuzosin—Infection—Gemcitabine—kidney cancer	0.000442	0.00105	CcSEcCtD
Alfuzosin—Back pain—Paclitaxel—kidney cancer	0.000442	0.00105	CcSEcCtD
Alfuzosin—Dizziness—Vinblastine—kidney cancer	0.000441	0.00105	CcSEcCtD
Alfuzosin—Dizziness—Everolimus—kidney cancer	0.000439	0.00105	CcSEcCtD
Alfuzosin—Abdominal pain—Sunitinib—kidney cancer	0.000439	0.00104	CcSEcCtD
Alfuzosin—Diarrhoea—Erlotinib—kidney cancer	0.000438	0.00104	CcSEcCtD
Alfuzosin—Hypotension—Vincristine—kidney cancer	0.000438	0.00104	CcSEcCtD
Alfuzosin—Nervous system disorder—Gemcitabine—kidney cancer	0.000437	0.00104	CcSEcCtD
Alfuzosin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000436	0.00104	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—kidney cancer	0.000433	0.00103	CcSEcCtD
Alfuzosin—Skin disorder—Gemcitabine—kidney cancer	0.000432	0.00103	CcSEcCtD
Alfuzosin—Rhinitis—Capecitabine—kidney cancer	0.000432	0.00103	CcSEcCtD
Alfuzosin—Hyperhidrosis—Gemcitabine—kidney cancer	0.00043	0.00103	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000429	0.00102	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000428	0.00102	CcSEcCtD
Alfuzosin—Pharyngitis—Capecitabine—kidney cancer	0.000427	0.00102	CcSEcCtD
Alfuzosin—Urinary tract disorder—Capecitabine—kidney cancer	0.000425	0.00101	CcSEcCtD
Alfuzosin—Vomiting—Vinblastine—kidney cancer	0.000424	0.00101	CcSEcCtD
Alfuzosin—Dizziness—Erlotinib—kidney cancer	0.000424	0.00101	CcSEcCtD
Alfuzosin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000424	0.00101	CcSEcCtD
Alfuzosin—Connective tissue disorder—Capecitabine—kidney cancer	0.000423	0.00101	CcSEcCtD
Alfuzosin—Vomiting—Everolimus—kidney cancer	0.000422	0.00101	CcSEcCtD
Alfuzosin—Urethral disorder—Capecitabine—kidney cancer	0.000422	0.00101	CcSEcCtD
Alfuzosin—Rash—Everolimus—kidney cancer	0.000419	0.000998	CcSEcCtD
Alfuzosin—Dermatitis—Everolimus—kidney cancer	0.000418	0.000997	CcSEcCtD
Alfuzosin—Headache—Vinblastine—kidney cancer	0.000418	0.000995	CcSEcCtD
Alfuzosin—Angioedema—Paclitaxel—kidney cancer	0.000417	0.000994	CcSEcCtD
Alfuzosin—Headache—Everolimus—kidney cancer	0.000416	0.000991	CcSEcCtD
Alfuzosin—Hypotension—Gemcitabine—kidney cancer	0.000416	0.000991	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—kidney cancer	0.000415	0.000989	CcSEcCtD
Alfuzosin—Asthenia—Sorafenib—kidney cancer	0.000414	0.000985	CcSEcCtD
Alfuzosin—Malaise—Paclitaxel—kidney cancer	0.000412	0.000981	CcSEcCtD
Alfuzosin—Vertigo—Paclitaxel—kidney cancer	0.00041	0.000977	CcSEcCtD
Alfuzosin—Syncope—Paclitaxel—kidney cancer	0.00041	0.000976	CcSEcCtD
Alfuzosin—Pruritus—Sorafenib—kidney cancer	0.000408	0.000972	CcSEcCtD
Alfuzosin—Vomiting—Erlotinib—kidney cancer	0.000407	0.000971	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000406	0.000966	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000405	0.000965	CcSEcCtD
Alfuzosin—Fatigue—Vincristine—kidney cancer	0.000405	0.000964	CcSEcCtD
Alfuzosin—Rash—Erlotinib—kidney cancer	0.000404	0.000963	CcSEcCtD
Alfuzosin—Dermatitis—Erlotinib—kidney cancer	0.000404	0.000962	CcSEcCtD
Alfuzosin—Palpitations—Paclitaxel—kidney cancer	0.000404	0.000961	CcSEcCtD
Alfuzosin—Eye disorder—Capecitabine—kidney cancer	0.000402	0.000958	CcSEcCtD
Alfuzosin—Headache—Erlotinib—kidney cancer	0.000401	0.000956	CcSEcCtD
Alfuzosin—Loss of consciousness—Paclitaxel—kidney cancer	0.000401	0.000956	CcSEcCtD
Alfuzosin—Pain—Vincristine—kidney cancer	0.000401	0.000956	CcSEcCtD
Alfuzosin—Constipation—Vincristine—kidney cancer	0.000401	0.000956	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—kidney cancer	0.000401	0.000956	CcSEcCtD
Alfuzosin—Flushing—Capecitabine—kidney cancer	0.0004	0.000952	CcSEcCtD
Alfuzosin—Cardiac disorder—Capecitabine—kidney cancer	0.0004	0.000952	CcSEcCtD
Alfuzosin—Asthenia—Sunitinib—kidney cancer	0.000398	0.000948	CcSEcCtD
Alfuzosin—Nausea—Vinblastine—kidney cancer	0.000396	0.000943	CcSEcCtD
Alfuzosin—Somnolence—Gemcitabine—kidney cancer	0.000396	0.000943	CcSEcCtD
Alfuzosin—Nausea—Everolimus—kidney cancer	0.000395	0.00094	CcSEcCtD
Alfuzosin—Diarrhoea—Sorafenib—kidney cancer	0.000394	0.00094	CcSEcCtD
Alfuzosin—Pruritus—Sunitinib—kidney cancer	0.000392	0.000935	CcSEcCtD
Alfuzosin—Angiopathy—Capecitabine—kidney cancer	0.000391	0.00093	CcSEcCtD
Alfuzosin—Arthralgia—Paclitaxel—kidney cancer	0.000389	0.000926	CcSEcCtD
Alfuzosin—Chest pain—Paclitaxel—kidney cancer	0.000389	0.000926	CcSEcCtD
Alfuzosin—Mediastinal disorder—Capecitabine—kidney cancer	0.000388	0.000924	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000386	0.00092	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000384	0.000916	CcSEcCtD
Alfuzosin—Discomfort—Paclitaxel—kidney cancer	0.000384	0.000915	CcSEcCtD
Alfuzosin—Fatigue—Gemcitabine—kidney cancer	0.000384	0.000914	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vincristine—kidney cancer	0.000384	0.000914	CcSEcCtD
Alfuzosin—Dizziness—Sorafenib—kidney cancer	0.000381	0.000908	CcSEcCtD
Alfuzosin—Pain—Gemcitabine—kidney cancer	0.000381	0.000907	CcSEcCtD
Alfuzosin—Constipation—Gemcitabine—kidney cancer	0.000381	0.000907	CcSEcCtD
Alfuzosin—Nausea—Erlotinib—kidney cancer	0.000381	0.000907	CcSEcCtD
Alfuzosin—Dry mouth—Paclitaxel—kidney cancer	0.00038	0.000906	CcSEcCtD
Alfuzosin—Diarrhoea—Sunitinib—kidney cancer	0.00038	0.000904	CcSEcCtD
Alfuzosin—Mental disorder—Capecitabine—kidney cancer	0.000377	0.000898	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—kidney cancer	0.000377	0.000898	CcSEcCtD
Alfuzosin—Oedema—Paclitaxel—kidney cancer	0.000373	0.000888	CcSEcCtD
Alfuzosin—Abdominal pain—Vincristine—kidney cancer	0.000371	0.000884	CcSEcCtD
Alfuzosin—Infection—Paclitaxel—kidney cancer	0.00037	0.000882	CcSEcCtD
Alfuzosin—Dizziness—Sunitinib—kidney cancer	0.000367	0.000874	CcSEcCtD
Alfuzosin—Feeling abnormal—Gemcitabine—kidney cancer	0.000367	0.000874	CcSEcCtD
Alfuzosin—Shock—Paclitaxel—kidney cancer	0.000367	0.000873	CcSEcCtD
Alfuzosin—Vomiting—Sorafenib—kidney cancer	0.000367	0.000873	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000366	0.000873	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000366	0.000873	CcSEcCtD
Alfuzosin—Nervous system disorder—Paclitaxel—kidney cancer	0.000365	0.000871	CcSEcCtD
Alfuzosin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000365	0.000869	CcSEcCtD
Alfuzosin—Tachycardia—Paclitaxel—kidney cancer	0.000364	0.000867	CcSEcCtD
Alfuzosin—Rash—Sorafenib—kidney cancer	0.000364	0.000866	CcSEcCtD
Alfuzosin—Dermatitis—Sorafenib—kidney cancer	0.000363	0.000865	CcSEcCtD
Alfuzosin—Back pain—Capecitabine—kidney cancer	0.000362	0.000864	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—kidney cancer	0.000362	0.000864	CcSEcCtD
Alfuzosin—Skin disorder—Paclitaxel—kidney cancer	0.000362	0.000862	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000361	0.00086	CcSEcCtD
Alfuzosin—Headache—Sorafenib—kidney cancer	0.000361	0.00086	CcSEcCtD
Alfuzosin—Hyperhidrosis—Paclitaxel—kidney cancer	0.00036	0.000858	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—kidney cancer	0.000359	0.000856	CcSEcCtD
Alfuzosin—Vomiting—Sunitinib—kidney cancer	0.000353	0.00084	CcSEcCtD
Alfuzosin—Rash—Sunitinib—kidney cancer	0.00035	0.000833	CcSEcCtD
Alfuzosin—Dermatitis—Sunitinib—kidney cancer	0.000349	0.000833	CcSEcCtD
Alfuzosin—Hypotension—Paclitaxel—kidney cancer	0.000348	0.00083	CcSEcCtD
Alfuzosin—Ill-defined disorder—Capecitabine—kidney cancer	0.000348	0.000828	CcSEcCtD
Alfuzosin—Headache—Sunitinib—kidney cancer	0.000348	0.000828	CcSEcCtD
Alfuzosin—Nausea—Sorafenib—kidney cancer	0.000342	0.000816	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00034	0.000809	CcSEcCtD
Alfuzosin—Malaise—Capecitabine—kidney cancer	0.000338	0.000805	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—kidney cancer	0.000338	0.000804	CcSEcCtD
Alfuzosin—Vertigo—Capecitabine—kidney cancer	0.000337	0.000802	CcSEcCtD
Alfuzosin—Asthenia—Vincristine—kidney cancer	0.000337	0.000802	CcSEcCtD
Alfuzosin—Syncope—Capecitabine—kidney cancer	0.000336	0.000801	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—kidney cancer	0.000334	0.000795	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—kidney cancer	0.000333	0.000794	CcSEcCtD
Alfuzosin—Somnolence—Paclitaxel—kidney cancer	0.000331	0.000789	CcSEcCtD
Alfuzosin—Palpitations—Capecitabine—kidney cancer	0.000331	0.000789	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—kidney cancer	0.000331	0.000789	CcSEcCtD
Alfuzosin—Nausea—Sunitinib—kidney cancer	0.00033	0.000785	CcSEcCtD
Alfuzosin—Loss of consciousness—Capecitabine—kidney cancer	0.000329	0.000785	CcSEcCtD
Alfuzosin—Dyspepsia—Paclitaxel—kidney cancer	0.000328	0.000782	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000322	0.000768	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000322	0.000766	CcSEcCtD
Alfuzosin—Fatigue—Paclitaxel—kidney cancer	0.000321	0.000765	CcSEcCtD
Alfuzosin—Diarrhoea—Vincristine—kidney cancer	0.000321	0.000765	CcSEcCtD
Alfuzosin—Asthenia—Gemcitabine—kidney cancer	0.000319	0.000761	CcSEcCtD
Alfuzosin—Arthralgia—Capecitabine—kidney cancer	0.000319	0.00076	CcSEcCtD
Alfuzosin—Chest pain—Capecitabine—kidney cancer	0.000319	0.00076	CcSEcCtD
Alfuzosin—Constipation—Paclitaxel—kidney cancer	0.000319	0.000759	CcSEcCtD
Alfuzosin—Pain—Paclitaxel—kidney cancer	0.000319	0.000759	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000317	0.000755	CcSEcCtD
Alfuzosin—Discomfort—Capecitabine—kidney cancer	0.000315	0.000751	CcSEcCtD
Alfuzosin—Pruritus—Gemcitabine—kidney cancer	0.000315	0.00075	CcSEcCtD
Alfuzosin—Dry mouth—Capecitabine—kidney cancer	0.000312	0.000743	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—kidney cancer	0.000312	0.000743	CcSEcCtD
Alfuzosin—Dizziness—Vincristine—kidney cancer	0.00031	0.000739	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—kidney cancer	0.000309	0.000736	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—kidney cancer	0.000309	0.000736	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—kidney cancer	0.000309	0.000736	CcSEcCtD
Alfuzosin—Feeling abnormal—Paclitaxel—kidney cancer	0.000307	0.000732	CcSEcCtD
Alfuzosin—Oedema—Capecitabine—kidney cancer	0.000306	0.000729	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000305	0.000726	CcSEcCtD
Alfuzosin—Diarrhoea—Gemcitabine—kidney cancer	0.000305	0.000726	CcSEcCtD
Alfuzosin—Infection—Capecitabine—kidney cancer	0.000304	0.000724	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000303	0.000722	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—kidney cancer	0.000301	0.000718	CcSEcCtD
Alfuzosin—Shock—Capecitabine—kidney cancer	0.000301	0.000717	CcSEcCtD
Alfuzosin—Nervous system disorder—Capecitabine—kidney cancer	0.0003	0.000715	CcSEcCtD
Alfuzosin—Thrombocytopenia—Capecitabine—kidney cancer	0.000299	0.000713	CcSEcCtD
Alfuzosin—Tachycardia—Capecitabine—kidney cancer	0.000298	0.000711	CcSEcCtD
Alfuzosin—Vomiting—Vincristine—kidney cancer	0.000298	0.000711	CcSEcCtD
Alfuzosin—Skin disorder—Capecitabine—kidney cancer	0.000297	0.000708	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—kidney cancer	0.000296	0.000706	CcSEcCtD
Alfuzosin—Urticaria—Paclitaxel—kidney cancer	0.000296	0.000705	CcSEcCtD
Alfuzosin—Rash—Vincristine—kidney cancer	0.000296	0.000705	CcSEcCtD
Alfuzosin—Hyperhidrosis—Capecitabine—kidney cancer	0.000296	0.000704	CcSEcCtD
Alfuzosin—Dermatitis—Vincristine—kidney cancer	0.000296	0.000704	CcSEcCtD
Alfuzosin—Abdominal pain—Paclitaxel—kidney cancer	0.000295	0.000702	CcSEcCtD
Alfuzosin—Headache—Vincristine—kidney cancer	0.000294	0.0007	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000292	0.000696	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—kidney cancer	0.00029	0.000691	CcSEcCtD
Alfuzosin—Hypotension—Capecitabine—kidney cancer	0.000286	0.000681	CcSEcCtD
Alfuzosin—Vomiting—Gemcitabine—kidney cancer	0.000283	0.000674	CcSEcCtD
Alfuzosin—Rash—Gemcitabine—kidney cancer	0.000281	0.000669	CcSEcCtD
Alfuzosin—Dermatitis—Gemcitabine—kidney cancer	0.00028	0.000668	CcSEcCtD
Alfuzosin—Headache—Gemcitabine—kidney cancer	0.000279	0.000664	CcSEcCtD
Alfuzosin—Nausea—Vincristine—kidney cancer	0.000279	0.000664	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000279	0.000664	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—kidney cancer	0.000278	0.000663	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—kidney cancer	0.000275	0.000656	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000274	0.000653	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000273	0.00065	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—kidney cancer	0.000272	0.000648	CcSEcCtD
Alfuzosin—Dyspepsia—Capecitabine—kidney cancer	0.000269	0.000641	CcSEcCtD
Alfuzosin—Asthenia—Paclitaxel—kidney cancer	0.000267	0.000637	CcSEcCtD
Alfuzosin—Nausea—Gemcitabine—kidney cancer	0.000264	0.00063	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000264	0.000629	CcSEcCtD
Alfuzosin—Fatigue—Capecitabine—kidney cancer	0.000264	0.000628	CcSEcCtD
Alfuzosin—Pruritus—Paclitaxel—kidney cancer	0.000264	0.000628	CcSEcCtD
Alfuzosin—Pain—Capecitabine—kidney cancer	0.000262	0.000623	CcSEcCtD
Alfuzosin—Constipation—Capecitabine—kidney cancer	0.000262	0.000623	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—kidney cancer	0.000259	0.000618	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—kidney cancer	0.000258	0.000614	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—kidney cancer	0.000258	0.000614	CcSEcCtD
Alfuzosin—Diarrhoea—Paclitaxel—kidney cancer	0.000255	0.000607	CcSEcCtD
Alfuzosin—Feeling abnormal—Capecitabine—kidney cancer	0.000252	0.0006	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—kidney cancer	0.000252	0.0006	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Capecitabine—kidney cancer	0.00025	0.000596	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—kidney cancer	0.00025	0.000596	CcSEcCtD
Alfuzosin—Dizziness—Paclitaxel—kidney cancer	0.000246	0.000587	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—kidney cancer	0.000243	0.000579	CcSEcCtD
Alfuzosin—Urticaria—Capecitabine—kidney cancer	0.000243	0.000579	CcSEcCtD
Alfuzosin—Abdominal pain—Capecitabine—kidney cancer	0.000242	0.000576	CcSEcCtD
Alfuzosin—Vomiting—Paclitaxel—kidney cancer	0.000237	0.000564	CcSEcCtD
Alfuzosin—Rash—Paclitaxel—kidney cancer	0.000235	0.00056	CcSEcCtD
Alfuzosin—Dermatitis—Paclitaxel—kidney cancer	0.000235	0.000559	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—kidney cancer	0.000234	0.000557	CcSEcCtD
Alfuzosin—Headache—Paclitaxel—kidney cancer	0.000233	0.000556	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000224	0.000534	CcSEcCtD
Alfuzosin—Nausea—Paclitaxel—kidney cancer	0.000221	0.000527	CcSEcCtD
Alfuzosin—Asthenia—Capecitabine—kidney cancer	0.000219	0.000523	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—kidney cancer	0.000218	0.000519	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—kidney cancer	0.000217	0.000517	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—kidney cancer	0.000217	0.000516	CcSEcCtD
Alfuzosin—Pruritus—Capecitabine—kidney cancer	0.000216	0.000515	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—kidney cancer	0.000213	0.000509	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—kidney cancer	0.000212	0.000506	CcSEcCtD
Alfuzosin—Diarrhoea—Capecitabine—kidney cancer	0.000209	0.000499	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—kidney cancer	0.000206	0.00049	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—kidney cancer	0.000206	0.00049	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000204	0.000487	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—kidney cancer	0.000203	0.000484	CcSEcCtD
Alfuzosin—Dizziness—Capecitabine—kidney cancer	0.000202	0.000482	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—kidney cancer	0.000201	0.000479	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—kidney cancer	0.000197	0.00047	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—kidney cancer	0.000196	0.000467	CcSEcCtD
Alfuzosin—Vomiting—Capecitabine—kidney cancer	0.000194	0.000463	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—kidney cancer	0.000194	0.000462	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—kidney cancer	0.000193	0.000461	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000193	0.00046	CcSEcCtD
Alfuzosin—Rash—Capecitabine—kidney cancer	0.000193	0.000459	CcSEcCtD
Alfuzosin—Dermatitis—Capecitabine—kidney cancer	0.000193	0.000459	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—kidney cancer	0.000192	0.000458	CcSEcCtD
Alfuzosin—Headache—Capecitabine—kidney cancer	0.000192	0.000456	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—kidney cancer	0.000191	0.000456	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000191	0.000454	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—kidney cancer	0.000184	0.000439	CcSEcCtD
Alfuzosin—Nausea—Capecitabine—kidney cancer	0.000182	0.000433	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00018	0.000428	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—kidney cancer	0.000175	0.000418	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—kidney cancer	0.000174	0.000413	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00017	0.000405	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—kidney cancer	0.00017	0.000405	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—kidney cancer	0.000169	0.000402	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—kidney cancer	0.000169	0.000402	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—kidney cancer	0.000162	0.000387	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000161	0.000384	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—kidney cancer	0.000157	0.000373	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—kidney cancer	0.000156	0.000371	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—kidney cancer	0.000141	0.000337	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—kidney cancer	0.000139	0.000332	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—kidney cancer	0.000135	0.000321	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—kidney cancer	0.00013	0.000311	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—kidney cancer	0.000125	0.000299	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—kidney cancer	0.000124	0.000296	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—kidney cancer	0.000124	0.000296	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—kidney cancer	0.000124	0.000294	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—kidney cancer	0.000117	0.000279	CcSEcCtD
